Lactoferrin immunoprophylaxis for very preterm infants

Archives of Disease in Childhood: Fetal and Neonatal Edition

Volumn 98, Issue 1, 2013, Pages

  McGuire, William ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE; LACTOFERRIN;

ANTIBIOTIC THERAPY; ANTIMICROBIAL ACTIVITY; ARTIFICIAL MILK; ARTIFICIAL VENTILATION; BIOFILM; BLOODSTREAM INFECTION; BRAIN HEMORRHAGE; COAGULASE NEGATIVE STAPHYLOCOCCUS; COLOSTRUM; COST EFFECTIVENESS ANALYSIS; DOSE RESPONSE; DRUG EXPOSURE; EDITORIAL; ENTEROCOLITIS; HUMAN; IMMUNOPROPHYLAXIS; INFECTION CONTROL; INFECTION RISK; INTENSIVE CARE UNIT; LACTOBACILLUS RHAMNOSUS; LONG TERM CARE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MORBIDITY; PREDICTIVE VALUE; PREMATURITY; PRIORITY JOURNAL; RETROLENTAL FIBROPLASIA; TREATMENT DURATION; VANCOMYCIN RESISTANT ENTEROCOCCUS; VERY LOW BIRTH WEIGHT;

ADMINISTRATION, ORAL; ANTI-INFECTIVE AGENTS; ENTEROCOLITIS, NECROTIZING; HUMANS; INFANT, NEWBORN; INFANT, PREMATURE, DISEASES; INFECTION CONTROL; LACTOFERRIN; SEPSIS;

EID: 84871614573     PISSN: 13592998     EISSN: 14682052     Source Type: Journal    
DOI: 10.1136/archdischild-2011-301273     Document Type: Editorial

References (34)

1. Berrington JE, Hearn RI, Bythell M, et al. Deaths in preterm infants: changing pathology over 2 decades. J Pediatr 2012;160:49-53.
2. Vergnano S, Menson E, Kennea N, et al. Neonatal infections in England: the NeonIN surveillance network. Arch Dis Child Fetal Neonatal Ed 2011;96:F9-14.
3. Samanta S, Farrer K, Breathnach A, et al. Risk factors for late onset gram-negative infections: a case-control study. Arch Dis Child Fetal Neonatal Ed 2011;96:F15-18.
4. Isaacs D, Australasian Study Group for Neonatal Infections. A ten year, multicentre study of coagulase negative staphylococcal infections in Australasian neonatal units. Arch Dis Child Fetal Neonatal Ed 2003;88:F89-93. (Pubitemid 36269526)
5. Isaacs D, Fraser S, Hogg G, et al. Staphylococcus aureus infections in Australasian neonatal nurseries. Arch Dis Child Fetal Neonatal Ed 2004:F331-5.
6. Clerihew L, Lamagni TL, Brocklehurst P, et al. Invasive fungal infection in very low birthweight infants: national surveillance study. Arch Dis Child Fetal Neonatal Ed 2006;91:188-92.
7. Adams-Chapman I, Stoll BJ. Neonatal infection and long-term neurodevelopmental outcome in the preterm infant. Curr Opin Infect Dis 2006;19:290-7. (Pubitemid 43740369)
8. Bassler D, Stoll BJ, Schmidt B, et al. Using a count of neonatal morbidities to predict poor outcome in extremely low birth weight infants: added role of neonatal infection. Pediatrics 2009;123:313-18.
9. Stoll BJ, Hansen NI, Adams-Chapman I, et al. Neurodevelopmental and growth impairment among extremely low-birth-weight infants with neonatal infection. JAMA 2004;292:2357-65. (Pubitemid 39491920)
10. Malik A, Hui CP, Pennie RA, et al. Beyond the complete blood cell count and C-reactive protein: a systematic review of modern diagnostic tests for neonatal sepsis. Arch Pediatr Adolesc Med 2003;157:511-16. (Pubitemid 36693540)
11. Isaacs D. Unnatural selection: reducing antibiotic resistance in neonatal units. Arch Dis Child Fetal Neonatal Ed 2009;91:F72-4. (Pubitemid 43059208)
12. Murphy BP, Armstrong K, Ryan CA, et al. Benchmarking care for very low birthweight infants in Ireland and Northern Ireland. Arch Dis Child Fetal Neonatal Ed 2010;95:F30-5.
13. Lee SK, Aziz K, Singhal N, et al. Improving the quality of care for infants: a cluster randomised controlled trial. CMAJ 2009;181:469-76.
14. Renfrew MJ, Craig D, Dyson L, et al. Breastfeeding promotion for infants in neonatal units: a systematic review and economic analysis. Health Technol Assess 2009;13:1-146.
15. Ochoa TJ, Cleary TG. Effect of lactoferrin on enteric pathogens. Biochimie 2009;91:30-4.
16. Valenti P, Antonini G. Lactoferrin: an important host defence against microbial and viral attack. Cell Mol Life Sci 2005;62:2576-87. (Pubitemid 41721231)
17. Legrand D, Pierce A, Elass E, et al. Lactoferrin structure and functions. Adv Exp Med Biol 2008;606:163-94.
18. González-Chávez SA, Arévalo-Gallegos S, Rascón-Cruz Q. Lactoferrin: structure, function and applications. Int J Antimicrob Agents 2009;33:301. e1-8.
19. Tian H, Maddox IS, Ferguson LR, et al. Influence of bovine lactoferrin on selected probiotic bacteria and intestinal pathogens. Biometals 2010;23:593-6.
20. Actor JK, Hwang SA, Kruzel ML. Lactoferrin as an immune modulator. Curr Pharm Des 2009;15:1956-73.
21. Berlutti F, Schippa S, Morea C, et al. Lactoferrin downregulates pro-inflammatory cytokines upexpressed in intestinal epithelial cells infected with invasive or noninvasive E. coli strains. Biochem Cell Biol 2006;84:351-7. (Pubitemid 44341310)
22. Wakabayashi H, Takakura N, Yamauchi K, et al. Modulation of immunity-related gene expression in small intestines of mice by oral lactoferrin. Clin Vaccine Immunol 2006;13:239-45. (Pubitemid 43383793)
23. Vorland LH, Ulvatne H, Andersen J, et al. Lactoferricin of bovine origin is more active than lactoferricins of human, murine and caprine origin. Scand J Infect Dis 1998;30:513-17. (Pubitemid 29054360)
24. Terrin G, Passariello A, De Curtis M, et al. Ranitidine is associated with infections, necrotizing enterocolitis, and fatal outcome in newborns. Pediatrics 2012;129:e40-5.
25. Buccigrossi V, de Marco G, Bruzzese E, et al. Lactoferrin induces concentration-dependent functional modulation of intestinal proliferation and differentiation. Pediatr Res 2007;61:410-14. (Pubitemid 46569292)
26. Raghuveer TS, McGuire EM, Martin SM, et al. Lactoferrin in the preterm infants ' diet attenuates iron-induced oxidation products. Pediatr Res 2002;52:964-72. (Pubitemid 35379480)
27. Scott PH. Plasma lactoferrin levels in newborn preterm infants: effect of infection. Ann Clin Biochem 1989;26:412-15. (Pubitemid 19228831)
28. Yamauchi K, Toida T, Nishimura S, et al. 13-Week oral repeated administration toxicity study of bovine lactoferrin in rats. Food Chem Toxicol 2000;38:503-12. (Pubitemid 30319350)
29. Kawakami H, Lönnerdal B. Isolation and function of a receptor for human lactoferrin in human fetal intestinal brush-border membranes. Am J Physiol 1991;261:G841-6.
30. Hochwallner H, Schulmeister U, Swoboda I, et al. Microarray and allergenic activity assessment of milk allergens. Clin Exp Allergy 2010;40:1809-18.
31. Manzoni P, Rinaldi M, Cattani S, et al. Bovine lactoferrin supplementation for prevention of late-onset sepsis in very low-birth-weight neonates: a randomized trial. JAMA 2009;302:1421-8.
32. Venkatesh MP, Abrams SA. Oral lactoferrin for the prevention of sepsis and necrotizing enterocolitis in preterm infants. Cochrane Database Syst Rev 2010;(5):CD007137.
33. Manzoni P, Stolfi I, Messner H, et al. Bovine lactoferrin prevents invasive fungal infections in very low birth weight infants: a randomized controlled trial. Pediatrics 2012;129:116-23.
34. Modi N, Doré CJ, Saraswatula A, et al. A case definition for national and international neonatal bloodstream infection surveillance. Arch Dis Child Fetal Neonatal Ed 2009;94:F8-12.